A Phosphatase Holoenzyme Comprised of Shoc2/Sur8 and the Catalytic Subunit of PP1 Functions as an M-Ras Effector to Modulate Raf Activity

Cited by (215)

Items 101–200 of 215

1. Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells
   Pui–Kei Wu, Seung‐Keun Hong, Jong‐In Park · 2017 · Molecular and Cellular Biology
2. Isolation of a Novel Thioflavin S–Derived Compound That Inhibits BAG-1–Mediated Protein Interactions and Targets BRAF Inhibitor–Resistant Cell Lines
   Marion Enthammer, Emmanouil S. Papadakis, Maria Salomé Gachet, Martin Deutsch, Stefan Schwaiger, Katarzyna Kozieł, Muhammad Ashraf, Sana Khalid, Gerhard Wolber, Graham Packham et al. · 2013 · Molecular Cancer Therapeutics
3. Targeting the SHOC2–RAS interaction in RAS-mutant cancers
   Zachary J. Hauseman, Frédéric Stauffer, Kim S. Beyer, Sandra Mollé, Elena Cavicchioli, Jean‐Rémy Marchand, Michelle Fodor, Jessica S. Viscomi, Anxhela Dhembi, Stéphanie Katz et al. · 2025 · Nature
4. Functional Integration of the Conserved Domains of Shoc2 Scaffold
   Myoungkun Jeoung, Lina G. Abdelmoti, Eun Ryoung Jang, Craig W. Vander Kooi, Emilia Galperin · 2013 · PLoS ONE
5. M‐Ras induces Ral and JNK activation to regulate MEK/ERK‐independent gene expression in MCF‐7 breast cancer cells
   Castro, Ariel F., Campos, Tania, Babcock, Justin T., Armijo, Marisol E., Martínez‐Conde, Alfonso, Pincheira, Roxana, Quilliam, Lawrence A. · 2012 · Journal of Cellular Biochemistry
6. Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors
   Lo Lai, Nicole D. Fer, William E. Burgan, Vanessa E. Wall, Bingfang Xu, Daniel R. Soppet, Dominic Esposito, Dwight V. Nissley, Frank P. McCormick · 2022 · Proceedings of the National Academy of Sciences
7. Sur8/Shoc2 Involves Both Inhibition of Differentiation and Maintenance of Self-Renewal of Neural Progenitor Cells via Modulation of Extracellular Signal-Regulated Kinase Signaling
   Byoung-San Moon, Hyun-Yi Kim, Mi‐Yeon Kim, Donghwa Yang, Jong‐Min Lee, Kyoung‐Won Cho, Han-Sung Jung, Kang‐Yell Choi · 2010 · Stem Cells
8. AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion
   Seung‐Keun Hong, Joseph H. Jeong, Andrew Man-Lok Chan, Jong‐In Park · 2013 · Experimental Cell Research
9. Clinical and functional characterization of a novel RASopathy‐causingSHOC2mutation associated with prenatal‐onset hypertrophic cardiomyopathy
   Marialetizia Motta, Antonella Giancotti, Gioia Mastromoro, Balasubramanian Chandramouli, Valentina Pinna, Francesca Pantaleoni, Niccolò Di Giosaffatte, Stefania Petrini, Tommaso Mazza, Valentina D’Ambrosio et al. · 2019 · Human Mutation
10. Targeting the PI3K and MAPK pathways to treat Kaposi’s sarcoma-associated herpes virus infection and pathogenesis
    Phelps J. Lambert, Aniqa Shahrier, Audy G. Whitman, Ossie F. Dyson, Adrian J Reber, James Andrew McCubrey, Shaw M. Akula · 2007 · Expert Opinion on Therapeutic Targets
11. Raf‐interactome in tuning the complexity and diversity of Raf function
    Su An, Yang Yang, Richard John Ward, Ying Liu, Xiao‐Xi Guo, Tian‐Rui Xu · 2014 · FEBS Journal
12. SHOC2 subcellular shuttling requires the KEKE motif-rich region andN-terminal leucine-rich repeat domain and impacts on ERK signalling
    Marialetizia Motta, Giovanni Chillemi, Valentina Fodale, Serena Cecchetti, Simona Coppola, Silvia Stipo, Viviana Cordeddu, Pompeo Macioce, Bruce D. Gelb, Marco Tartaglia · 2016 · Human Molecular Genetics
13. New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling
    Keesha E. Erickson, Oleksii S. Rukhlenko, Richard G. Posner, William S. Hlavacek, Boris Ν. Kholodenko · 2018 · Seminars in Cancer Biology
14. Expanding the molecular spectrum of pathogenicSHOC2variants underlying Mazzanti syndrome
    Marialetizia Motta, Maja Šolman, Adeline Alice Bonnard, Alma Kuechler, Francesca Pantaleoni, Manuela Priolo, Balasubramanian Chandramouli, Simona Coppola, Simone Pizzi, Erika Zara et al. · 2022 · Human Molecular Genetics
15. Kidins220/ARMS binds to the B cell antigen receptor and regulates B cell development and activation
    Gina J. Fiala, Iga Janowska, Fabiola Prutek, Elias Hobeika, Annyesha Satapathy, Adrian Sprenger, Thomas Plum, Maximilian Seidl, Jörn Dengjel, Michael G. Reth et al. · 2015 · The Journal of Experimental Medicine
16. Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
    Huang Xiao-pei, Ji‐Kuai Chen, Wei Xue, Yi-Fan Dong, Lang Yan, Xiaofang Zhang, Ya‐min Pan, Chang Wen-jun, Zhu Jiangbo · 2018 · Bioscience Reports · Retracted
17. A brief history of RAS and the RAS Initiative
    Frank P. McCormick · 2022 · Advances in cancer research
18. M-Ras evolved independently of R-Ras and its neural function is conserved between mammalian and ascidian, which lacks classical Ras
    Etsuko Keduka, Ai Kaiho, Mayuko Hamada, Haruko Watanabe‐Takano, Kazunori Takano, Michio Ogasawara, Yutaka Satou, Nori Satoh, Takeshi Endo · 2008 · Gene
19. Polycistronic baculovirus expression of SUGT1 enables high-yield production of recombinant leucine-rich repeat proteins and protein complexes
    Kelly Snead, Vanessa E. Wall, Hannah Ambrose, Dominic Esposito, Matthew R. Drew · 2022 · Protein Expression and Purification
20. Shoc2-tranduced ERK1/2 motility signals — Novel insights from functional genomics
    Myoungkun Jeoung, Eun Ryoung Jang, Jinpeng Liu, Chi Wang, Eric Christian Rouchka, Xiaohong Li, Emilia Galperin · 2016 · Cellular Signalling
21. Interrogating PP1 Activity in the MAPK Pathway with Optimized PP1‐Disrupting Peptides
    Yansong Wang, Bernhard Hoermann, Karolina Pavic, Malgorzata Trebacz, Pablo Ríos, Maja Köhn · 2018 · ChemBioChem
22. Conquering oncogenic KRAS and its bypass mechanisms
    Pingping Hou, Yanru Wang · 2022 · Theranostics
23. Raf kinases in signal transduction and interaction with translation machinery
    Nunzia Migliaccio, Carmen Sanges, Immacolata Ruggiero, Nicola M. Martucci, Emilia Rippa, Paolo Arcari, Annalisa Lamberti · 2013 · BioMolecular Concepts
24. Swimming toward solutions: Using fish and frogs as models for understanding RASopathies
    Victoria L. Patterson, Rebecca D. Burdine · 2020 · Birth Defects Research
25. A novel antitubulin agent, DPQZ, induces cell apoptosis in human oral cancer cells through Ras/Raf inhibition and MAP kinases activation
    Mann‐Jen Hour, Kun-Tsung Denzel Lee, Yang‐Chang Wu, Chi-Yu Wu, Bang‐Jau You, Tai‐Lin Chen, Hong‐Zin Lee · 2012 · Archives of Toxicology
26. How Genetics Has Helped Piece Together the MAPK Signaling Pathway
    Dariel Ashton‐Beaucage, Marc Therrien · 2016 · Methods in molecular biology
27. Noonan syndrome with loose anagen hair with variants in the PPP1CB gene: First familial case reported
    Victoria Huckstadt, Josefina Chinton, Abel Gomez, María Gabriela Obregón, Luis Pablo Gravina · 2021 · American Journal of Medical Genetics Part A
28. The overview of Mitogen-activated extracellular signal-regulated kinase (MEK)-based dual inhibitor in the treatment of cancers
    Hao Wang, Lingling Chi, Fuqiang Yu, Hongling Dai, Xiaojie Si, Chao Gao, Zhengjie Wang, Limin Liu, Jiaxin Zheng, Yu Ke et al. · 2022 · Bioorganic & Medicinal Chemistry
29. The Function of Embryonic Stem Cell-expressed RAS (E-RAS), a Unique RAS Family Member, Correlates with Its Additional Motifs and Its Structural Properties
    Saeideh Nakhaei‐Rad, Hossein Nakhaeizadeh, Claus Kordes, Ion Cristian Cirstea, Malte Schmick, Radovan Dvorský, Philippe I. H. Bastiaens, Dieter Häussinger, Mohammad Reza Ahmadian · 2015 · Journal of Biological Chemistry
30. CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
    Michal Alon, Rand Arafeh, Joo Sang Lee, Sanna Madan, Shelly Kalaora, Adi Nagler, Tereza Abgarian, Polina Greenberg, Eytan Ruppin, Yardena Samuels · 2018 · Oncotarget
31. M-RAS Regulate CDH1 Function in Blastomere Compaction during Porcine Embryonic Development
    Dongjie Zhou, Yingjie Niu, Xiang‐Shun Cui · 2020 · Journal of Animal Reproduciton and Biotechnology
32. M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras
    Takeshi Endo · 2020 · Experimental Cell Research
33. Shoc2 recognizes bacterial flagellin and mediates antibacterial Erk/Stat signaling in an invertebrate
    Bao-Rui Zhao, Xinxin Wang, Xian-Wei Wang · 2022 · PLoS Pathogens
34. The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model
    Mingjia Tan, Yu Chang, Xiaoqiang Liu, Hua Li, Zaiming Tang, Mukesh Kumar Nyati, Yi Sun · 2022 · Cell Reports
35. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy
    María Fernanda Montenegro, Román Martí-Díaz, Ana Navarro, Jorge Tolivia, Luís Sánchez‐del‐Campo, Juan Cabezas‐Herrera, José Neptuno Rodríguez‐López · 2023 · Cell Death and Disease
36. RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations
    Daniel A. Bonsor, Dhirendra K. Simanshu · 2023 · Annual Review of Cancer Biology
37. Cryo-EM Structures of CRAF2/14-3-32 and CRAF2/14-3-32/MEK12 Complexes
    Dirk Dedden, Julius Nitsche, Elisabeth V. Schneider, Maren Thomsen, Daniel F. Schwarz, Birgitta Leuthner, Ulrich Grädler · 2024 · Journal of Molecular Biology
38. Exploiting bacterial effector proteins to uncover evolutionarily conserved antiviral host machinery
    Aaron Embry, Nina S. Baggett, David B. Heisler, Addison White, Maarten F. de Jong, Benjamin L. Kocsis, Diana R. Tomchick, Neal M. Alto, Don B. Gammon · 2024 · PLoS Pathogens
39. VCP/p97 controls signals of the ERK1/2 pathway transmitted via the Shoc2 scaffolding complex: novel insights into IBMPFD pathology
    HyeIn Jang, Eun Ryoung Jang, Patricia G. Wilson, D. Anderson, E. Galperin · 2019 · Molecular Biology of the Cell
40. Transcriptional hallmarks of noonan syndrome and noonan‐like syndrome with loose anagen hair
    Giovanni Battista Ferrero, Gabriele Picco, Giuseppina Baldassarre, Elisabetta Flex, Claudio Isella, Daniela Cantarella, Davide Corà, Nicoletta Chiesa, Nicoletta Crescenzio, Fabio Stefano Timeus et al. · 2012 · Human Mutation
41. MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor
    Miguel A. Miranda-Román, Cindy J. Lee, Eve Fishinevich, Leili Ran, Amish J. Patel, Juan Yan, Makhzuna N. Khudoynazarova, Sarah Warda, Mohini R. Pachai, Yu Chen et al. · 2024 · Clinical Cancer Research
42. La signalisation RTK/RAS/ERK élargie
    Dariel Ashton‐Beaucage, Marc Therrien · 2010 · médecine/sciences
43. Structural keys unlock RAS–MAPK cellular signalling pathway
    Hugo Lavoie, Marc Therrien · 2022 · Nature
44. SHOC2 is associated with the survival of breast cancer cells and has prognostic value for patients with breast cancer
    Wenwen Geng, Ke Dong, Qian Pu, Yanrong Lv, Haidong Gao · 2019 · Molecular Medicine Reports
45. Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds
    Elva Morretta, Adama Sidibé, Andrea Spallarossa, Antonello Petrella, Elda Meta, Olga Bruno, Maria Chiara Monti, Chiara Brullo · 2021 · European Journal of Medicinal Chemistry
46. Ras effector switching as a developmental strategy
    David J. Reiner · 2011 · Small GTPases
47. The small GTPase MRAS is a broken switch
    Gabriela Bernal Astrain, Regina Strakhova, Chang Hwa Jo, Emma Teszner, Ryan C. Killoran, Matthew James Smith · 2025 · Nature Communications
48. RAS-pathies: Noonan syndrome and other related diseases. The literature review
    Mariya V Faassen · 2014 · Problems of Endocrinology
49. Structural insights into the role of SHOC2‐MRAS‐PP1C complex in RAF activation
    Daniel A. Bonsor, Dhirendra K. Simanshu · 2023 · FEBS Journal
50. MRAS in coronary artery disease—Unchartered territory
    Pashmina Wiqar Shah, Tobias Reinberger, Satwat Hashmi, Zouhair Aherrahrou, Jeanette Erdmann · 2024 · IUBMB Life
51. Sur8 mediates tumorigenesis and metastasis in colorectal cancer
    Young Mi Lee, Saluja Kaduwal, Kug Hwa Lee, Jong‐Chan Park, Woo-Jeong Jeong, Kang‐Yell Choi · 2016 · Experimental & Molecular Medicine
52. The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair
    Patricia G. Wilson, Lina G. Abdelmoti, Rebecca G. Norcross, Eun Ryoung Jang, Malathy Palayam, Emilia Galperin · 2021 · Journal of Cell Science
53. Natural history of MRAS‐related Noonan syndrome: Evidence of mild adult‐onset left ventricular hypertrophy and neuropsychiatric features
    Manuela Priolo, Cecilia Mancini, Francesca Clementina Radio, Luigi Chiriatti, Andrea Ciolfi, Camilla Cappelletti, Viviana Cordeddu, Letizia Pintomalli, Alfredo Brusco, Corrado Mammì et al. · 2023 · American Journal of Medical Genetics Part C Seminars in Medical Genetics
54. Red Blood Cell BCL-xL Is Required for Plasmodium falciparum Survival: Insights into Host-Directed Malaria Therapies
    Coralie Boulet, Ghizal Siddiqui, Taylah L. Gaynor, Christian Doerig, Darren J. Creek, Teresa Gil Carvalho · 2022 · Microorganisms
55. Case report: A de novo RASopathy-causing SHOC2 variant in a Chinese girl with noonan syndrome-like with loose anagen hair
    Qingming Wang, Shuangxi Cheng, Youqing Fu, Haiming Yuan · 2022 · Frontiers in Genetics
56. Functional links between diacylglycerol and phosphatidylinositol signaling systems in human leukocyte-derived cell lines
    Ho Yin Poon, James C. Stone · 2009 · Biochemical and Biophysical Research Communications
57. Reconstitution and characterization of BRAF in complex with 14‐3‐3 and KRAS4B on nanodiscs
    Ningdi Feng Liu, Masahiro Enomoto, Christopher B. Marshall, Mitsuhiko Ikura · 2024 · Protein Science
58. Stabilization of Sur8 via PKCα/δ degradation promotes transformation and migration of colorectal cancer cells
    Kug Hwa Lee, Woo-Jeong Jeong, Pu-Hyeon Cha, Sang Gyu Lee, Do Sik Min, Kang‐Yell Choi · 2017 · Oncotarget
59. The RASopathies: Syndromes of Ras/MAPK Pathway Dysregulation
    William E. Tidyman, Katherine A. Rauen · 2012 · Springer eBooks
60. Shoc2/Sur8 Protein Regulates Neurite Outgrowth
    Gonzalo León‐Espinosa, Lucía Sánchez‐Ruiloba, Andrea Pérez-Rodríguez, Teresa Gragera, Natalia J. Martinez, Silvia F. Hernandez, Berta Anta, Olga Calero, Carlota A. García-Domínguez, Lara M. Dura et al. · 2014 · PLoS ONE
61. SUR-8 interacts with PP1-87B to stabilize PERIOD and regulate circadian rhythms in Drosophila
    Yongbo Xue, Joanna C. Chiu, Yong Zhang · 2019 · PLoS Genetics
62. Single-domain antibodies for functional targeting of the signaling scaffold Shoc2
    Hyein Jang, Patricia G. Wilson, Mary Sau, Udeep Chawla, David W. Rodgers, Emilia Galperin · 2019 · Molecular Immunology
63. A feature selection approach for identification of signature genes from SAGE data
    Júnior Barrera, Roberto Marcondes Cesar Junior, Carlos Humes, David Martins, Diogo Ferreira da Costa Patrão, Paulo J. S. Silva, Helena Brentani · 2007 · BMC Bioinformatics
64. Cell signalling and radiation survival: The impact of protein phosphatases
    Julie Hamilton, Eric J. Bernhard · 2009 · International Journal of Radiation Biology
65. SHOCing RAF into action
    Helen R. Mott, Darerca Owen · 2022 · Nature Structural & Molecular Biology
66. SHOC2 plays an oncogenic or tumor-suppressive role by differentially targeting the MAPK and mTORC1 signals in liver cancer
    Xia-Hong You, Longyu Dou, Mingjia Tan, Xiufang Xiong, Yi Sun · 2024 · Life Medicine
67. Revisiting RAS family GTPase signaling: effector selectivity and oncogenic bypass
    Dhirendra K. Simanshu, Frank P. McCormick · 2026 · Biochemical Journal
68. SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells
    Vanessa S. Silveira, Kleiton Silva Borges, Verena Silva Santos, Mariana T. Ruckert, Gabriela Maciel Vieira, Elton J. R. Vasconcelos, Luís Fernando Peinado Nagano, Luíz Gonzaga Tone, Carlos Alberto Scrideli · 2020 · Scientific Reports
69. Molecular Genetics of Noonan Syndrome and Other RASopathies
    Marialetizia Motta, Elisabetta Flex, Simone Martinelli, Marco Tartaglia · 2024 · Springer eBooks
70. Whole‐genome CRISPR‐Cas9 knockout screens identify SHOC2 as a genetic dependency in NRAS ‐mutant melanoma
    Andrea Y. Gu, Tet Woo Lee, Aziza Khan, Xuenan Zhang, Francis W. Hunter, Dean C. Singleton, Stephen M. F. Jamieson · 2025 · 癌症：英文版
71. Characteristics and advances in signaling pathways, cellular communication, cell junctions, and oxidative stress in lymphedema
    Qiancheng Zhao, Zhipu Niu, Ying Pan, Yongqi Hao, Yuan Ma, Jiankai Zhao, Jianshi Du, Yi Yang · 2025 · Frontiers in Cell and Developmental Biology
72. Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma
    Sarah E. Henson, Travis Morford, Mary‐Pat Stein, Randolph Wall, Cindy Sue Malone · 2010 · Acta Histochemica
73. Signaling scaffold Shoc2 regulates lymphangiogenesis by suppressing mTORC1-mediated IFN responses
    Patricia G. Wilson, Vishakha Vishwakarma, Rebecca G. Norcross, Kashmira Khaire, Van N. Pham, Brant M. Weinstein, Hyun Min Jung, Emilia Galperin · 2026 · Cell Death and Differentiation
74. Biotechnological Applications of Phosphate Solubilizing Microorganisms: Biological Alternative to Improve Phosphorus Availability
    Fatima Zahra Aliyat, Mohammed El Guilli, Laila Nassiri, Jamal Ibijbijen · 2024 · Microorganisms for sustainability
75. Gene regulatory network reconstruction and pathway inference from high throughput gene expression data
    Weijun Luo · 2008 · Deep Blue (University of Michigan)
76. Arabidopsis BSL phosphatases regulate zygote polarity through a brassinosteroid-independent essential function in MAP kinase signaling
    Sangho Jeong, Gabriel Eschedor, Magdy Alabady, Wolfgang Lukowitz · 2026 · Proceedings of the National Academy of Sciences
77. The expression of congenital Shoc2 variants induces AKT-dependent crosstalk activation of the ERK1/2 pathway
    Patricia G. Wilson, Lina G. Abdelmoti, Tianyan Gao, Emilia Galperin · 2024 · Human Molecular Genetics
78. Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation
    Lin Zhang, Arnold Bolomsky, Omar S. Al‐Odat, Callie K. VanWinkle, Aaliyah Battle, Papiya Chakraborty, Ronald J. Holewinski, Þorkell Andrésson, Björn Häupl, Thomas Oellerich et al. · 2026 · Blood Cancer Discovery
79. SOS1 inhibitor combinations overcome KRAS inhibitor resistance
    2024 · Nature Cancer
80. RNA interference knock-down suggests that PIRL6 functions in the male gametophyte of Arabidopsis thaliana
    Savannah R. McNichol · 2016
81. Short Chain Fatty Acids (SCFAs) delay the pathogenesis of Hepatitis B Virus (HBV)-associated Hepatocellular Carcinoma (HCC)
    Noreen McBrearty · 2019 · TUScholarShare (Temple University)
82. Analyse der Auswirkungen von Aminosäuresubstitutionen im humanen CBL-Protein auf die Regulation des epidermalen Wachstumsfaktorrezeptors (EGFR)
    Hendrik Kentsch · 2012
83. Studies on signaling pathways induced by FLT3, an important oncogene in AML
    Elena Razumovskaya · 2011 · Lund University Publications (Lund University)
84. A structural and functional study on Cot (MAPKKK8)
    Binhui Wu · 2008
85. Experimental and theoretical modelling of the MAPK pathway
    Louise Elizabeth Maddison · 2012 · Research Explorer (The University of Manchester)
86. Análise do perfil de expressão de genes relacionados à resistência a quimioterápicos na leucemia linfóide aguda da criança e do adolescente
    Vanessa S. Silveira · 2018
87. Sequenciamento paralelo em larga escala de genes alvo é uma ferramenta útil no diagnótico etiológico de crianças nascidas pequenas para idade gestacional
    Bruna Lucheze Freire · 2018
88. Efeito do silenciamento de SHOC2 na sobrevivência e no controle do estresse oxidativo em linhagens celulares de adenocarcinoma ductal pancreático
    Camilla Rodrigues Pereira Borges · 2019
89. Raf Kinase
    Evan T. Keller · 2016 · Springer eBooks
90. The role of novel antisense long non-coding RNA, GHRLOS, in prostate and endometrial cancer
    Esha T. Shah · 2021 · Queensland University of Technology
91. Raf Kinase
    Evan T. Keller · 2014 · Springer eBooks
92. Raf Kinase
    Evan T. Keller · 2008 · Springer eBooks
93. Faculty Opinions recommendation of M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell-cell adhesion during collective cell migration.
    Ruth Nussinov · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
94. Raf Kinase
    Evan T. Keller · 2011 · Springer eBooks
95. Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
    Sisi Chen, Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang, Salima Benbarche, Katherine L. B. Knorr, Won Jun Kim, Robert F. Stanley et al. · 2023
96. Introduction to RAS biology
    Channing J. Der, Frank McCormick · 2024 · Elsevier eBooks
97. Aberrant expression of MRAS and HEG1 as the biomarkers for osimertinib resistance in LUAD
    Mingxin Liu, Bo Tang, Run Xiang, Peihong Hu, Chuan Shan Xu, Lanlin Hu, Qiang Li · 2024 · Discover Oncology
98. RAS Family Interactions: The SHOC2-MRAS-PP1 Complex in Noonan Syndrome
    Isabel Boned del Río, Pablo Rodriguez‐Viciana · 2024 · Springer eBooks
99. The Noncanonical RAS/MAPK Pathway and the RASopathies
    Stephanie Mo, Pau Castel · 2024 · Springer eBooks
100. Blocking a key node in cancer signalling unlocks therapeutic potential
     Hugo Lavoie, Marc Therrien · 2025 · Nature